Featuring news, events and industry trends
25 Students in Westchester County Among 300 Scholars Selected for 2022 Regeneron Science Talent Search

Society for Science (the Society) announced the top 300 scholars in the Regeneron Science Talent Search 2022, the nation's oldest and most prestigious science and math competition for high school seniors. The 300 scholars and their schools will be awarded $2,000 each. Twenty-five students from Westchester County were selected for this prestigious competition.

Scholars were chosen based on their exceptional research skills, commitment to academics, innovative thinking and promise as scientists as demonstrated through the submission of their original, independent research projects, essays and recommendation. The 300 scholars hail from 185 American and international high schools in 37 states, China, Switzerland, and Singapore, including three homeschools.

The full list of scholars can be viewed here: https://www.societyforscience.org/regeneron-sts/2022-scholars/ 

BASF partners with China BlueChemical and Wuhuan Engineering to develop new technology for use
of CO2-rich marine gas

BASF, with a state-of-the-art research center in Tarrytown, signed a joint development agreement with China BlueChemical Limited Company (China BlueChemical), a leading natural gas producer, and the chemical engineering company Wuhuan Engineering Co., Ltd. (Wuhuan Engineering) to promote low-carbon development and utilization of marine gas resources.

Marine gas, unlike the commercial natural gas, contains high concentrations of CO2. The gas needs CO2 removal to be usable for downstream large-scale applications.
BASF will leverage its extensive expertise in catalyst development and will collaborate with the two companies to solve these challenges. Through technical innovation in reforming catalysts, special reactor design and related process technology development, BASF’s solution will improve process energy efficiency and carbon efficiency beyond existing commercial catalyst and process technology. The partnerships will promote lower-carbon development and utilization of marine gas resources, and ultimately achieve an economically competitive and environmentally friendly commercial process.

BASF CEO Martin Brudermuller leads
2022 ICIS Top 40 Power Players

BASF CEO Martin Brudermuller has been named #1 in the 2022 ICIS Top 40 Power Players, a global ranking of the leading CEOs and senior executives making the greatest positive impact on their companies and the chemicals industry.                                                                                                              

BASF is working to scale up two key decarbonisation technologies Brudermuller believes will be game changers by the second half of the decade - electric cracking and methane pyrolysis.      
The ICIS Top 40 Power Players ranking in the 7 January issue of ICIS Chemical Business is available for download here.
Owens & Minor, Inc. Signs Definitive Agreement
to Acquire Apria, Inc.

Owens & Minor, Inc. (“Owens & Minor”) and Apria, Inc. (“Apria”), with presence in Elmsford, announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.
Regeneron and Ultragenyx Collaborate to Commercialize Evkeeza® (evinacumab) Outside the United States

This includes the European Economic Area, where Evkeeza was approved in June 2021 as a first-in-class therapy for use together with diet and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to treat adults and adolescents aged 12 years and older with homozygous familial hypercholesterolemia (HoFH). Regeneron discovered and developed Evkeeza, and launched the medicine in the U.S. in February 2021 when it was approved by the FDA.
Central New York Biotech Accelerator Now Accepting Applications for 2022 Medical Device Innovation Challenge

The CNYBAC Medical Device Innovation Challenge is a 6-month intensive mentorship / network expansion / resource rich program for early-stage innovators. This highly competitive program accepts 5-6 teams each year to participate. To date, 26 teams have graduated from the program and have amassed milestone achievements during and following their participation. The MDIC serves as a complement and a pipeline to other incubation/acceleration programs.

Applications are accepted January 1 through April 30 each year and are reviewed through a due diligence process performed by The Innovation Law Center, Syracuse University. Participants are selected by the MDIC Review Committee - interviews may be convened to assist in team selection. The program starts August 1 (some teams receive early commercialization research in advance of program start). You may participate virtually or on-site. If on-site, you receive 6-months of free work space in the CNYBC Creation Garage, 841 E. Fayette St., Syracuse, NY. All selected teams can utilize this facility at any point in time during the program. 
Opportunities with ContraFect

Yonkers-headquartered, ContraFect is a clinical stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. There are several job openings with ContraFect offering a terrific opportunity to grow in an environment that is both challenging and energetic. ContraFect is seeking self-motivated and collaborative individuals to join the team and to contribute their talent and expertise.
Check out the ContraFect careers site for the latest available opportunities:
This position is responsible for the operational execution for ContraFect’s Early Discovery and CMC programs. The incumbent must have prior drug development experience (preferably with biologics) and ensure seamless integration of operational activities and scientific imperatives to make certain execution, scientific excellence and delivery of programs are within time, cost and quality parameters.  

Seeking an experienced toxicologist to provide support for conducting toxicology studies at CROs. 
JelikaLite Closes $700,000 StartEngine Campaign

JelikaLite, a WCBA alum, has raised $700,000 through a StartEngine campaign. JelikaLite believes that children on the spectrum can lead fulfilling and productive lives, which is why they are developing Cognilum, an innovative medical solution to permanently reduce a child's autism symptoms, enabling better integration into society and reducing lifetime costs.
Apply to Pitch at Dolphin Tank: Digital Health

Springboard Enterprises, Accenture and Black Girl Ventures have teamed up to present a Dolphin Tank event series to elevate Black female founders in February 2022. The team is looking for Black women founders who are innovating in digital health tech to improve the way people access, receive, manage and finance healthcare. Learn more and apply to pitch here.
Apply to Pitch at Invest NY: Health

Calling all startups in the HealthIT, medical devices and life sciences! Invest NY: Health will take place on March 3 and is currently looking for companies with a tech-enabled & defensible market position (intellectual property and market traction all count) and some (or lots) of proven product/market fit. Applicants who have raised some outside capital are ideal and there is a preference for late-seed/series A or later companies. You can view the application here. The deadline to apply is February 4.
WCBA Alum, JelikaLite, to Speak During Princeton Entrepreneurship Council’s 2nd Annual Women Founders Startup Showcase
on January 27
Westchester County Biosciences Accelerator alumnus JelikaLite (Eugenia Steingold ‘00) is among six outstanding founders who will be featured during the Princeton Entrepreneurship Council’s 2nd Annual Women Founders Startup Showcase on January 27 from 5:00 PM to 7:00 PM. Eugenia will share an overview of JelikaLite and answer questions from the audience. At the conclusion of the presentations, each audience member will cast his/her vote for the “best of the best” startup.
Invest NY: Health on March 3

Invest NY is an event series highlighting impactful innovations in important industry sectors. Each event features startups, VC & PE investors, and industry leaders from across New York and beyond. This event is dedicated to highlighting innovation in Health. The event will take place in-person and online.

Have good news to share from
Westchester’s biosciences ecosystem?

Please let us know.

If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.